Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEV to RevenueEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to EarningsPrice to Sales
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Rallybio (RLYB) Enterprise Value (2023 - 2025)

Rallybio (RLYB) has disclosed Enterprise Value for 3 consecutive years, with -$54.7 million as the latest value for Q4 2025.

  • Quarterly Enterprise Value rose 16.45% to -$54.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$54.7 million through Dec 2025, up 16.45% year-over-year, with the annual reading at -$54.7 million for FY2025, 16.45% up from the prior year.
  • Enterprise Value hit -$54.7 million in Q4 2025 for Rallybio, up from -$59.3 million in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$45.7 million in Q2 2025 to a low of -$150.4 million in Q1 2023.
  • Historically, Enterprise Value has averaged -$88.1 million across 3 years, with a median of -$81.9 million in 2024.
  • Biggest YoY gain for Enterprise Value was 48.37% in 2025; the steepest drop was 16.45% in 2025.
  • Year by year, Enterprise Value stood at -$109.9 million in 2023, then soared by 40.41% to -$65.5 million in 2024, then grew by 16.45% to -$54.7 million in 2025.
  • Business Quant data shows Enterprise Value for RLYB at -$54.7 million in Q4 2025, -$59.3 million in Q3 2025, and -$45.7 million in Q2 2025.